Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
100.0%
% of XLV's 60 holdings also in IXJ
53.6%
% of IXJ's 113 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 9.6% | 9.6% |
|
UNITEDHEALTH GROUP INC | 8.5% | 6.0% | 6.0% |
|
JOHNSON & JOHNSON | 7.7% | 5.5% | 5.5% |
|
ABBVIE INC | 6.2% | 4.4% | 4.4% |
|
ABBOTT LABORATORIES | 4.6% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IXJ
|
ELI LILLY & CO | 3.8% |
|
UNITEDHEALTH GROUP INC | 2.4% |
|
JOHNSON & JOHNSON | 2.2% |
|
ABBVIE INC | 1.8% |
|
ABBOTT LABORATORIES | 1.3% |
|
MERCK & CO. INC. | 1.1% |
|
INTUITIVE SURGICAL INC | 1.0% |
|
THERMO FISHER SCIENTIFIC INC | 0.9% |
|
AMGEN INC | 0.9% |
|
BOSTON SCIENTIFIC CORP | 0.8% |
XLV Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.2% |
|
NOVARTIS AG | -3.2% |
 |
ASTRAZENECA PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
 |
SANOFI-AVENTIS | -1.6% |
|
ESSILOR INTERNATIONAL | -1.2% |
 |
CSL LIMITED | -1.1% |
|
GSK PLC | -1.1% |
|
LONZA GROUP AG-REG | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |